Predicting Postrecurrence Survival Among Completely Resected Nonsmall-Cell Lung Cancer Patients

The proposed prediction instrument offers clinicians a succinct tool for rapidly evaluating mortality risk after recurrence. The characteristics comprising this instrument can be easily ascertained and measured, making it of potential clinical value.